Medtech investments hold up despite market turmoil

After 2021’s $9.9bn outlier year for medtech venture money, on the surface the $7.4bn raised in 2022 looks like a return to normality, with last year’s tally on a par with the $7.3bn raised in 2020. But what might come as a concern is the huge fall in both the amount invested and the number of investments seen in the fourth quarter.